Corinthian Colleges Inc (NASDAQ:COCO) posted its quarterly earnings results on Tuesday. The company reported $0.03 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.05 by $0.02, Analyst Ratings Net reports. The company had revenue of $349.80 million for the quarter, compared to the consensus estimate of $355.13 million. During the same quarter in the prior year, the company posted $0.04 earnings per share. Corinthian Colleges Inc (NASDAQ:COCO) shares after opening at $1.08 moved to $1.08 on last trade day and at the end of the day closed at $ 0.899 . Company price to sales ratio in past twelve months was calculated as 0.05 and price to cash ratio as 2.39. Corinthian Colleges Inc (NASDAQ:COCO) showed a negative weekly performance of -21.86 %.
The Wet Seal Inc (NASDAQ:WTSL) has been given a consensus recommendation of “Hold” by the eight brokerages that are currently covering the company, American Banking News.com reports. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. The Wet Seal, Inc. (NASDAQ:WTSL) shares fell -6.36% in last trading session and ended the day on $1.03. WTSL return on equity ratio is recorded as -35.30% and its return on assets is -18.10%. The Wet Seal, Inc. (NASDAQ:WTSL) yearly performance is -70.57%.
Endeavour International Corporation (NYSE:END) reported first quarter 2014 net loss, as adjusted of $27.3 million compared to a net loss, as adjusted of $12.1 million for the same period in 2013. On a GAAP basis, net loss for the first quarter was $44.9 million as compared to net loss of $14.0 million for the same quarter in 2013. Endeavour International Corporation (NYSE:END) shares moved down -25.66% in last trading session and was closed at $2.52 while trading in range of $2.51 – $3.12 – Endeavour International Corporation (NYSE:END) year to date (YTD) performance is -52.00%.
Zacks upgraded shares of BioTelemetry Inc (NASDAQ:BEAT) from a neutral rating to an outperform rating in a research report released on Tuesday morning, StockRatingsNetwork.com reports. Zacks currently has $9.40 price objective on the stock. BioTelemetry, Inc. (NASDAQ:BEAT) weekly performance is -26.74%. On last trading day company shares ended up $6.86. BioTelemetry, Inc. (NASDAQ:BEAT) distance from 50-day simple moving average (SMA50) is -27.24%. Analysts mean target price for the company is $5.94.